Physician profile
Jonas S Benson
NPI 1841450525
$9,977.02
in general payments reported to CMS, 2019-2025
34 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $47.27 · 2021: $6,309 · 2022: $342 · 2023: $1,109 · 2024: $698 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,790 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,789.78 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,154.78 | 2019-2021 | |
| Boston Scientific Corporation | $809.17 | 2019-2025 | General - Erectile Dysfunction, Ams 700 |
| Dendreon Pharmaceuticals LLC | $475.67 | 2023-2025 | Provenge |
| Coloplast Corp | $322.59 | 2022-2023 | Speedicath |
| Sumitomo Pharma America, INC. | $280.82 | 2023-2025 | Gemtesa, Orgovyx |
| Angiodynamics, INC. | $164.30 | 2022-2023 | Nanoknife |
| Bayer Healthcare Pharmaceuticals INC. | $152.06 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $150.86 | 2025 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $147.85 | 2023-2024 | Bard Urinary Drainage Bag |
| Merck Sharp & Dohme LLC | $135.36 | 2024-2025 | Keytruda |
| Ferring Pharmaceuticals INC. | $132.30 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $107.55 | 2024-2025 | Erleada |
| Abbvie INC. | $106.01 | 2023-2025 | Lupron Depot |
| Progenics Pharmaceuticals, INC. | $92.71 | 2025 | |
| Convatec INC. | $80.50 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $78.17 | 2022-2023 | Axonics, Bulkamid |
| Antares Pharma, INC. | $71.69 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Procept Biorobotics Corporation | $63.41 | 2024 | Aquabeam System |
| Dentsply Ih INC. | $59.81 | 2019 | |
| Endo Pharmaceuticals INC. | $56.54 | 2020-2023 | Aveed, Edex, Xiaflex |
| Laborie Medical Technologies Corp. | $49.35 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Avation Medical, INC. | $41.69 | 2025 | Vivally System |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Tempus Ai, INC | $28.68 | 2024 | |
| Urogen Pharma, INC. | $22.78 | 2025 | |
| Accord Healthcare, INC. | $21.46 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $18.76 | 2019 | |
| Teleflex LLC | $18.45 | 2022 | |
| Myriad Genetic Laboratories, INC. | $17.90 | 2023 | Prolaris |
| Calyxo, INC. | $16.73 | 2025 | Cvac Aspiration System |
| Endo USA, INC. | $16.68 | 2025 | Aveed, Xiaflex |
| Cook Medical LLC | $16.59 | 2023 | Fiber Dust |
| Neotract INC. | $16.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonas Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.